Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-03 | Blueprint Medicines Corp | Namouni Fouad
(PRESIDENT, R & D) |
S | Common Stock | D | 3633 | $89.32 - $89.32 | $324,499 |
| 2024-09-09 | Blueprint Medicines Corp | Albers Jeffrey W.
(Director) |
S | Common Stock | D | 19702 | $85.12 - $85.86 | $1,685,890 |
| 2024-09-09 | Blueprint Medicines Corp | Albers Jeffrey W.
(Director) |
M | Common Stock | A | 10000 | $36.05 - $36.05 | $360,500 |
| 2024-08-05 | Blueprint Medicines Corp | Lee Philina
(CHIEF COMMERCIAL OFFICER) |
S | Common Stock | D | 41913 | $93.19 - $93.19 | $3,905,872 |
| 2024-08-05 | Blueprint Medicines Corp | Lee Philina
(CHIEF COMMERCIAL OFFICER) |
M | Common Stock | A | 41913 | $36.05 - $86.60 | $2,828,917 |
| 2024-07-01 | Blueprint Medicines Corp | Carter Percy H.
(CHIEF SCIENTIFIC OFFICER) |
A | Common Stock | A | 7500 | $0.00 - $0.00 | $0 |
| 2024-07-01 | Blueprint Medicines Corp | Rossi Christina
(CHIEF OPERATING OFFICER) |
A | Common Stock | A | 9625 | $0.00 - $0.00 | $0 |
| 2024-06-12 | Blueprint Medicines Corp | Albers Jeffrey W.
(Director) |
A | Common Stock | A | 2242 | $0.00 - $0.00 | $0 |
| 2024-06-12 | Blueprint Medicines Corp | Beckman Daniella
(Director) |
A | Common Stock | A | 2242 | $0.00 - $0.00 | $0 |
| 2024-06-12 | Blueprint Medicines Corp | COATS LONNEL
(Director) |
A | Common Stock | A | 2242 | $0.00 - $0.00 | $0 |
| 2024-06-12 | Blueprint Medicines Corp | Tsai John
(Director) |
A | Common Stock | A | 2242 | $0.00 - $0.00 | $0 |
| 2024-06-12 | Blueprint Medicines Corp | Seely Lynn
(Director) |
A | Common Stock | A | 2242 | $0.00 - $0.00 | $0 |
| 2024-06-12 | Blueprint Medicines Corp | Lydon Nicholas
(Director) |
A | Common Stock | A | 2242 | $0.00 - $0.00 | $0 |
| 2024-06-12 | Blueprint Medicines Corp | Goldberg Mark Alan
(Director) |
A | Common Stock | A | 2242 | $0.00 - $0.00 | $0 |
| 2024-06-12 | Blueprint Medicines Corp | Borisy Alexis
(Director) |
A | Common Stock | A | 2242 | $0.00 - $0.00 | $0 |
| 2024-06-12 | Blueprint Medicines Corp | Dable Habib J
(Director) |
A | Common Stock | A | 2242 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |